Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma

NCT03463252 is registered in ClinicalTrials.gov with West China Second University Hospital as lead sponsor.

NCT NCT03463252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03463252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma
Lead sponsor
West China Second University Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 1, 2018
Completion date
December 30, 2030
Enrollment
224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, endometrial cancer